Skip to main content

Reactions Weekly

Ausgabe 1/2024

Inhalt (190 Artikel)

Case report

Ad26.COV2-S

Case report

Afatinib

Case report

Alectinib

Case report

Alendronic-acid

Case report

Alpelisib

Case report

Amiodarone

Case report

Amlodipine

Case report

Antibacterials

Case report

Antihyperglycaemics

Case report

Antineoplastics

Case report

Atezolizumab

Case report

Atezolizumab

Case report

Azathioprine

Case report

BCG-vaccine

Case report

Bevacizumab/cidofovir

Case report

Carboplatin/Etoposide

Case report

Carnitine

Case report

Cefepime

Case report

Cisplatin

Case report

Cisplatin/Gemcitabine

Case report

Cyclophosphamide

Case report

Dapagliflozin

Case report

Dapsone

Case report

Dapsone

Case report

Deferoxamine

Case report

Docetaxel

Case report

Dofetilide/nadolol

Case report

Doxycycline

Case report

Dronedarone

Case report

Dupilumab

Case report

Elasomeran

Case report

Eravacycline

Case report

Gefitinib/Osimertinib

Case report

Hydroxycarbamide

Case report

Ibrutinib

Case report

Ibrutinib

Case report

Immune-globulin

Case report

Immunosuppressants

Case report

Immunosuppressants

Case report

Immunotherapies

Case report

Infliximab

Case report

Ipilimumab/nivolumab

Case report

Lactulose/rifaximin

Case report

Larotrectinib

Case report

Levetiracetam

Case report

Levetiracetam

Case report

Linagliptin

Case report

Lithium

Case report

Meglumine-antimonate

Case report

Mepolizumab

Case report

Metamfetamine

Case report

Metronidazole

Case report

Moroctocog-alfa

Case report

Multiple drug

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Mutiple drugs

Case report

Nintedanib

Case report

Nintedanib

Case report

Niraparib

Case report

Nitrofurantoin

Case report

Nivolumab

Case report

Nivolumab

Case report

Norepinephrine

Case report

Nusinersen

Case report

Palbociclib

Case report

Pamidronic acid

Case report

Peginterferon-alfa

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Pheniramine

Case report

Phenytoin

Case report

Plasma

Case report

Pomalidomide

Case report

Pralidoxime-iodide

Case report

Prednisolone

Case report

Prednisolone

Case report

Prednisone

Case report

Progesterone

Case report

Rivaroxaban

Case report

Serplulimab

Case report

Sertraline

Case report

Sintilimab

Case report

Sintilimab

Case report

Tigecycline

Case report

Tocilizumab

Case report

Tozinameran

Case report

Tozinameran

Case report

Vitamin-K